TOT BIOPHARM International Company Limited
HKEX:1875.HK
2 (HKD) • At close September 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||
| Net Income
| -37.756 | -50.046 | -261.216 | -288.498 | -299.3 | -268.263 | -148.687 |
| Depreciation & Amortization
| 43.028 | 38.039 | 34.237 | 32.082 | 27.351 | 15.656 | 13.494 |
| Deferred Income Tax
| 0 | 7.347 | -4.177 | -2.568 | 26.123 | 25.512 | 42.325 |
| Stock Based Compensation
| 10.643 | 16.111 | 5.296 | 15.832 | 23.557 | 25.677 | 0.369 |
| Change In Working Capital
| 11.729 | 44.141 | 49.224 | -19.79 | -29.554 | 22.909 | -24.696 |
| Accounts Receivables
| -82.549 | -35.681 | -20.231 | 10.103 | -5.102 | -3.048 | 0.131 |
| Inventory
| -31.188 | -65.263 | -21.444 | 7.136 | -12.145 | -2.125 | -0.98 |
| Accounts Payables
| 0 | 0 | 0 | 0 | 5.102 | 3.048 | -0.131 |
| Other Working Capital
| 21.229 | 145.085 | 90.899 | -37.029 | -17.409 | 25.034 | -23.847 |
| Other Non Cash Items
| 2.201 | 4.337 | 1.499 | -0.174 | 0.494 | 1.677 | -0.193 |
| Operating Cash Flow
| 56.431 | 59.929 | -175.137 | -263.116 | -251.329 | -176.832 | -117.388 |
| Investing Activities: | |||||||
| Investments In Property Plant And Equipment
| -203.2 | -240.123 | -115.313 | -22.181 | -37.34 | -78.198 | -134.683 |
| Acquisitions Net
| -2.6 | -5.15 | -1.5 | -34.349 | 1.054 | 1.552 | 0.448 |
| Purchases Of Investments
| -280 | -255 | -6.902 | -365.57 | -131.8 | -116.5 | -60.3 |
| Sales Maturities Of Investments
| 321.215 | 215.634 | 8.402 | 399.919 | 118.019 | 147.631 | 84.026 |
| Other Investing Activites
| 33.176 | 1.875 | 6.92 | 34.707 | -1.035 | -1.552 | -0.448 |
| Investing Cash Flow
| -164.105 | -282.764 | -108.393 | 12.526 | -51.102 | -47.067 | -110.957 |
| Financing Activities: | |||||||
| Debt Repayment
| -56.652 | -196.191 | -1.494 | -60 | -0.5 | -68.193 | -1.333 |
| Common Stock Issued
| 0 | 405.788 | 1.99 | 0 | 541.952 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -3.376 | 271.643 | 211.586 | -1.707 | 41.57 | 525.794 | 236.512 |
| Financing Cash Flow
| 38.225 | 481.24 | 212.082 | -61.707 | 583.022 | 457.601 | 235.179 |
| Other Information: | |||||||
| Effect Of Forex Changes On Cash
| 3.28 | 6.559 | -1.28 | -1.35 | 1.838 | -1.532 | -2.297 |
| Net Change In Cash
| -66.169 | 264.964 | -72.728 | -313.647 | 282.429 | 232.17 | 4.537 |
| Cash At End Of Period
| 351.6 | 417.769 | 152.805 | 225.533 | 539.18 | 256.751 | 24.581 |